TCL Archive DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search June 22, 1984
TCL Archive FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes. April 27, 2007
TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says March 20, 1998
